|
|
|
MIRA INFORM REPORT
|
Report No. : |
507816 |
|
Report Date : |
10.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
NSF PHARMACEUTICALS CO LTD |
|
|
|
|
Registered Office : |
Block No. 51, Taif PO Box 10771 Khartoum |
|
|
|
|
Country : |
Sudan |
|
|
|
|
Date of Incorporation : |
2000 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Subject is engaged in the import and distribution of
pharmaceuticals and medicines. |
|
|
|
|
No. of Employees : |
22 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
Sudan |
D |
D |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
SUDAN - ECONOMIC
OVERVIEW
Sudan has experienced protracted social conflict, civil war, and, in July 2011, the loss of three-quarters of its oil production due to the secession of South Sudan. The oil sector had driven much of Sudan's GDP growth since 1999. For nearly a decade, the economy boomed on the back of rising oil production, high oil prices, and significant inflows of foreign direct investment. Since the economic shock of South Sudan's secession, Sudan has struggled to stabilize its economy and make up for the loss of foreign exchange earnings. The interruption of oil production in South Sudan in 2012 for over a year and the consequent loss of oil transit fees further exacerbated the fragile state of Sudan’s economy. Ongoing conflicts in Southern Kordofan, Darfur, and the Blue Nile states, lack of basic infrastructure in large areas, and reliance by much of the population on subsistence agriculture, keep close to half of the population at or below the poverty line.
Sudan was subject to comprehensive US sanctions, which were lifted in October 2017. Sudan is attempting to develop non-oil sources of revenues, such as gold mining and agriculture, while carrying out an austerity program to reduce expenditures. The world’s largest exporter of gum Arabic, Sudan produces 75-80% of the world’s total output. Agriculture continues to employ 80% of the work force.
Sudan introduced a new currency, still called the Sudanese pound, following South Sudan's secession, but the value of the currency has fallen since its introduction. Khartoum formally devalued the currency in June 2012, when it passed austerity measures that included gradually repealing fuel subsidies. Sudan also faces high inflation, which reached 47% on an annual basis in November 2012 but fell to about 35% per year in 2017.
|
Source
: CIA |
SUMMARY
Company Name : NSF PHARMACEUTICALS CO LTD
Country of Origin : Sudan
Legal Form : Limited Liability Company
Registration Date : 2000
Issued Capital : SD 1,000,000
Paid up Capital : SD 1,000,000
Total Workforce : 22
Activities : Distributors of pharmaceuticals and medicines
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
COMPANY
NAME
NSF PHARMACEUTICALS CO LTD
ADDRESS
Registered &
Physical Address
Location : Block No. 51, Taif
PO Box :
10771
Town :
Khartoum
Country :
Sudan
Telephone : (249-183) 566013 / 566014
Mobile :
(249-123) 455854 / 455839 / 455826 / (249-915) 040758
Email :
hr@nsfpharmaco.com / nsfpharmaceuticals@hotmail.com
Please note that subject’s previous address was, House No. 24, Block Th/K/Y, East Khartoum
Premises
Subject operates from a small suite of offices that are
rented and located in the Central Business Area of Khartoum
KEY
PRINCIPALS
Name Position
· Dr
Salama Omar Abu Baker Managing
Director
· Dr
Omar Abu Baker Director
· Mohamed
Omar Abu Baker Director
· Abu
Baker El Deriri Sales
Representative
· Ezz
Eddine Mohamed Sales
Representative
· Malkah
Mohamed Human
Resources Officer
LEGAL
FORM & OWNERS
Date
of Establishment : 2000
Legal
Form : Limited
Liability Company
Issued Capital : SD
1,000,000
Paid up Capital : SD
1,000,000
Name of Shareholder (s)
· Dr
Salama Omar Abu Baker
· Dr
Omar Abu Baker
· Mohamed
Omar Abu Baker
OPERATIONS
Activities: Engaged in the import and distribution
of pharmaceuticals and medicines.
Import Countries: Europe and the Far East
Subject has a workforce of 22 employees.
FINANCIAL
DATA
Companies registered in Sudan are not legally required to
make their accounts public and no financial information was released by the
company or submitted by outside sources.
BANKERS
·
Mashreq Bank PSC
PO
Box: 371
Baldia
Street
Khartoum
Tel: (249-183)
772881
Fax:
(249-183) 772969
PAYMENT
HISTORY
No complaints regarding subject’s payments have been
reported.
GENERAL
COMMENTS
The subject and its shareholders/owners have been searched in
the following databases; Office of Foreign Assets Control (OFAC), United
Nations Security Council Sanctions, Australian Sanctions List, US Consolidated
Sanctions List, EU Financial Sanctions List and UK Financial Sanctions List and
nothing adverse could be found on the exact names listed within the report.
During the course of this investigation nothing detrimental
was uncovered regarding subject’s operating history or the manner in which
payments are fulfilled. As such the company is considered to be a fair trade
risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 67.38 |
|
|
1 |
INR 91.09 |
|
Euro |
1 |
INR 79.75 |
|
SDG |
1 |
INR 3.70 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TRU |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.